South Asia’s Largest Pharmaceutical Event in Mumbai

MUMBAI, India, November 15, 2012 /PRNewswire/ –

The much awaited 3-day CPhI/P-MEC/ICSE/ BioPh exhibition for the pharmaceutical
industry is all set to open in Mumbai on November 21, 2012. The exhibition will have
participation of over 920 companies from all over the world, making it South Asia’s
largest pharmaceutical event. Visitor pre-registrations also show very encouraging numbers
of attendees from over 90 countries interested in visiting CPhI/P-MEC/ICSE/ BioPh.

According to the India Business Equity Foundation, the Indian pharmaceutical market is
set to double its exports to reach US$500 billion by 2014, thereby attracting the
attention of major global economies. Growing at a pace of 15% annually, it is no secret
that Generics are the major strength of the Indian pharmaceutical sector. With a strong
domestic market potential and the low-cost manufacturing advantage working in its favour,
India is set to become increasingly prominent on the global pharmaceutical landscape in
the near future.

Mr.Rajeev Kher, Additional Secretary, Department of Commerce, Ministry of Commerce and
Industry, will be the Guest of Honour at the inaugural session to be held on November 21,
2012. The platform will provide an opportunity for attendees and exhibitors to interact
and network with the industry players from the various segments within the field of
pharmaceutical ingredients, machinery, equipment & technology, contract services and
solutions. Onsite seminars will address various technology issues and the latest industry
trends.

The CPhI India Awards will recognise and appreciate the contribution and efforts of
the Indian pharmaceutical industry. There are seven broad categories identified for the
awards. The categories include innovation in quality, product development, cost, the
environment, Health & Safety (EHS), packaging and the lifetime achievement and Pharma
Personality of the Year awards. The process advisors for the awards are Ernst & Young.
Organised by UBM, the CPhI India Awards are supported by Pharmexcil and Brand India
Pharma. The evaluation for the awards will be done by an independent panel of senior
industry professionals. The award distribution event will be held on 21st November, 2012.

CPhI India Awards 2012 will be an elite gathering of industry leaders who will meet,
network and also attend a panel discussion on “Developing the Capability, Credibility and
Culture to penetrate deeper into the global value chain for the Indian Pharma Industry”.

About UBM India

UBM India is a part of UBM plc (http://www.ubm.com), a leading global business
media company. We inform markets and bring the world’s buyers and sellers together at
events, online, and in print, providing them with the information they need to do business
successfully. We organise leading industry trade exhibitions covering a wide range of
verticals which include Pharmaceuticals, Security, Food Ingredients, Jewellery, IT,
Nuclear Energy and Travel. With the confirmation of over 920 exhibitors and 26,000
attendees expected, CPhI India 2012 and its co-located events are the largest and most
comprehensive pharmaceutical industry events in South Asia. Focused on pharmaceutical
ingredients, machinery, equipment, research, outsourcing and bio-solutions for pharma, the
event brings together high-quality prospects that are actively looking for these products
and services.

        Contact
        C. Bhaskar
        Senior Manager - Marketing Communications
        UBM India Pvt. Ltd
        Mumbai
        India
        T: +91-(0)22-6612-2600/681
        E: bhaskar.chivukula@ubm.com

SOURCE CPhI India